This study is aimed to elucidate the effect of aerobic walking using watch-type pedometers with or without a heart rate checker, which may support to keep moderate exercise intensity. METHODS: Thirty one healthy subjects (mean age, 59.1 ± 5.0, 17 men and 14 women) were divided into 2 groups: the study group of 15 subjects (8 men and 7 women) using a pedometer with a heart rate checker and the control group of 16 subjects (9 men and 7 women) using a common pedometer checking heart rates by themselves. All participants tried aerobic walking exercises alone for 8 weeks, 5 days a week, for 45 minutes a day with an instructed exercise intensity 40 to 60%. The subjects underwent height, weight, body fat percentage, blood pressure, and hematological and blood chemistry tests before and after the study. In addition, all participants completed an aging and QOL questionnaire before and after the study. RESULTS: A decrease of systolic blood pressure (before-study value 140.2 ± 23.2 mmHg) by 3.7% and an increase of estrogen levels (by 37%) in women were observed in both groups. In a comparative study of the 2 groups, the study group showed significant improvements in "lethargy", "tinnitus", "early satiety", "constipation" and "arthralgia" as physical symptoms and in "difficulty in falling asleep" and "pessimism" as mental symptoms. CONCLUSIONS: Aerobic walking with a heart rate checker may help to maintain the exercise intensity within the range of 40% to 60% of maximum, thus resulted more desirable data than walking with self heart rate checking at one's own pace.
The objective of anti-aging medicine is to achieve longevity coupled with health. This means not simply to lengthen life but also to prevent the deterioration caused by aging and to allow completion of a healthy, happy lifespan while maintaining a high quality of life (QOL) 1,2) . Because anti-aging medicine is categorized as preventive medicine, the patient should undergo a complete medical evaluation to measure the degree of senescence before anti-aging medicine is prescribed. Treatment of aging consists of lifestyle therapies such as diet/exercise and medical therapies such as supplemental nutrition and hormone replacement. This can be managed by general practitioners as well as specialists in hospital and industrial settings. In modern times, obesity may be a factor in the development of so-called lifestyle-related diseases such as hypertension, diabetes mellitus, and hyperlipidemia, and therefore may adversely influence health, QOL and longevity.
In addition to conventional exercise and food therapies, antiaging treatments involving integrated and alternative medicine, Chinese medicine, acupuncture, and moxibustion have become more familiar. Although there have been many reports on the effectiveness of such therapies, the lack of common parameters applied in these studies have left general practitioners with the basic questions "how effective are these medicines/treatments and for which kinds of diseases?"
In our past research, we have evaluated the safety and effectiveness of supplements, health foods, medical devices, exercise equipment, and cosmetics on human aging and obesity by applying common parameters [3] [4] [5] . The degree and limits of the effectiveness of those products were clarified. In this study, we focus on walking, which is the most basic among exercise therapies, and investigate its effect on the body. Walking is the easiest and most effective method of exercise. Epidemiologic research has proved that "ten thousand steps a day" is the ideal 6) . The average number of steps taken in a day in Japan is 7,532 steps for men and 6,446 steps for women (according to The National Health and Nutrition Survey in Japan, 2004 6) ). The intensity of walking is important for the promotion of health, and the greatest benefit is derived from maintaining the heart rate that is 40% to 60% of maximum while walking (exercise intensity 40% to 60%) 7) . In this study, the effect of walking in healthy individuals was investigated in a comparative study wherein one group of subjects used pedometers to measure the number of steps and the heart rate while a control group without pedometers was verbally instructed to aim to maintain 40% to 60% of their maximum exercise intensity.
Enrollment of Subjects and Method of the Study ·Study Population
The secretariat of a radio show "Yugakusha" at TBS Radio & Communication recruited healthy subjects in their fifties and sixties who were able to express their agreement to be enrolled in this study with a submission of written consent. Exclusion criteria were taking medicines such as hormonal agents or antiosteoporosis medicine; having a chronic disease such as diabetes mellitus, or severe liver, kidney, heart, or blood disorders or other complications; and being judged by a physician as inappropriate to be enrolled.
An ethical committee was set up at Maressia Garden Clinic for the study, from which approval to proceed was obtained. The study was carried out in compliance with the study protocol as well as ethical principles based on the "Declaration of Helsinki" as revised at the General Assembly in Edinburgh in 2000. This study also obeyed "An ethical principle about an epidemiologic study" by the Ministry of Health, Labour and Welfare (http://www.niph.go.jp/wadai/ekigakurinri/ekigakurinrih170401/ shishin-all.pdf).
Study candidates were instructed not only about terms, locations, and methods of the study, but also about the expected advantages and disadvantages that might be experienced by enrolling in the study. The candidates were told that they could discontinue their participation at any moment for any reason without any disadvantages even after they decide to enroll in the study. Written consent was obtained from each subject.
A total of 31 subjects (mean age, 59.1 ± 5.0, 17 men and 14 postmenopausal women) were enrolled and divided into 2 groups: the study group of 15 subjects (8 men and 7 women) and the control group of 16 subjects (9 men and 7 women). The 2 groups were matched for body weight and ratio of men to women. There was no significant difference between 2 groups in background profiles ( Table 1) . No significant inter-group difference was noted in the other items measured before the study.
·Methods
Study group participants were asked to exercise by walking at 40% to 60% of their maximum heart rates as determined by a watch-type pedometer with a function to measure the heart rate (Pullsse, by SEIKO S-YARD CO., LTD, Tokyo) (hereafter, the product). When the heart rate exceeds the exercise intensity set by Karvonen's formula 7) ( Table 2) , a warning lamp blinks and instruction on decrease or increase of walking pace is indicated. The control group participants used a watch-type pedometer without heart rate checking function (Pedessa, by SEIKO S-YARD CO., LTD) and were verbally instructed to maintain their walking exercise intensity at 40%-60% of their maximum heart rate by themselves counting the radial artery pulsation. The study period was set at 8 weeks from September 26, 2004 to November 21, 2004 . All the subjects in the study group were instructed how to wear and use the product by personnel from SEIKO S-YARD CO., LTD in writing or in briefing sessions.
All participants tried aerobic walking exercises for 8 weeks, 5 days a week, for 45 minutes a day alone (without coaching). A participant chose the walking course freely in one's neighborhood. The subjects underwent height, weight, body fat percentage, blood pressure, and hematological and blood chemistry tests before and after the study. Clinical tests were implemented at Mareesia Clinic (Shinjuku-ku, Tokyo) under a physician's administration. In addition, all participants completed an aging and QOL questionnaire before and after the study [3] [4] [5] . The body component was measured by the impedance method using a body composition analyzer (InBody520; BIOSPACE, Seoul, Korea).
Criteria for discontinuation of the study were decided by the physician in charge and included serious disease or exacerbation of a pre-existing disease (including complications).
·Statistical analysis
A statistical analysis of the results was performed using the paired t-test, non-paired t-test, or non-parametric test (Wilcoxon's signed rank test) for comparison of the values between the before ( A ) and the 8 weeks after( B ) in each group. For inter-group comparison, the values of difference ( B ÷ A ) was analyzed by Wilcoxon's signed rank test. The relationship between each parameter was tested using Pearson's correlation coefficient. A value of p<0.05 was considered to indicate a statistically significant change. Table 2 Karvonen's formula
Target heart rate = (Maximum heart rate -Resting heart rate) Exercise intensity + Resting heart rate · Maximum heart rate: [220 -actual age] · Resting heart rate: pulse rate (heart rate) per minute at rest. · Exercise intensity: 40% to 60% (0.4 to 0.6)
Results

·Test results
Two subjects from the study group and one from the control group withdrew from the study because of personal reasons. No adverse events were observed.
The results of the clinical laboratory testing are shown in Table 3A and 3B. Both the study group and the control group showed significant decreases in total body water (-1.61% and -1.49% respectively), muscle volume (-1.61% and -1.47%, respectively), lean body weight (-1.61% and -1.48%, respectively) and skeletal muscle volume (-1.95% and -2.30%, respectively) after the study period, however, the extent of the decreases was within 2.3% and was very small (p < 0.05). Both the study group and the control group showed an increase in body fat amount by more than 3% (3.13% and 3.18%, respectively) (p < 0.01). The waist-hip ratio and values of basal metabolism showed significant changes but the extent of the changes was within 1.1%. The systolic blood pressure of the study group decreased significantly from 144.5 ± 25.2 mmHg to 137.7 ± 25.2 mmHg (-4.75%, p < 0.05), but there was no significant change in the control group.
In the hematological and blood chemistry tests, the leukocyte counts of the study group changed by -16.8% (p < 0.05), and the blood creatinine of the control group changed by -6.19% (p < 0.01), but the clinical significance of these changes is unknown. In the hormonal tests, levels of insulin-like growth factor-I (IGF-I), dehydroepiandrosterone sulfate (DHEA-s), and total testosterones (men only) did not change while estrogen levels (women only) significantly increased by 21.58% in the study group and by 49.15% in the control group (p < 0.05).
Of the items relating to aging and QOL that were listed in the common questionnaire, physical symptoms are shown in Table  4A and 4B. In the study group 1 of 30 items, "lethargy" was significantly relieved. In the control group 2 items, "no feeling of good health" and "easily breaking into sweat" were significantly relieved. The items that were significantly exacerbated was one item, "skin problems" in the study group and 3 items, "liable to 
catch colds", "tinnitus" and "arthralgia" in the control group. Of the items relating to aging and the QOL that were listed in the common questionnaire, mental symptoms are shown in Table  5A and 5B. In the study group significant improvement in 2 items of 21, "loss of motivation" and "inability to solve problems," was found. In the control group, 1 item, "irritability," was significantly improved. No item was significantly exacerbated in either group. 
·Study group vs. control group
The comparison of the study group and the control group was analyzed by using a test of various rates (Table 6A , 6B, and 6C). More specifically, the rate, "after-study value ÷ before-study value" for each item was analyzed by nonparametric analysis. No significant difference was found between the study group and the control group in the "after-study value ÷ before-study value" of the items that changed significantly before and after the study such as total body water, muscle volume, lean body weight and skeletal muscle volume, body fat amount, body fat percentage, waist-hip ratio, and values of basal metabolism. Regarding the significant change of systolic blood pressure found only in the study group, there was no significant difference between the 2 groups.
In the clinical blood tests, "after-study value ÷ before-study value" of leukocyte count, blood creatinine, mean corpuscular volume, mean corpuscular hemoglobin concentration, sodium, and calcium had no significant difference between the 2 groups. In the hormone tests, "after-study value ÷ before-study value" of IGF-I, DHEA-s, total testosterone, and estrogen levels had no significant difference between the 2 groups. The "after-study score ÷ before-study score" of the "physical symptoms" listed in the common questionnaire was analyzed in a similar manner. In 5 items of 30 there were significant differences: for "lethargy" the rate in the study group was 0.79 ± 0.23 while that of the control group was 1.20 ± 0.61 (p = 0.002), for "tinnitus" the rate of the study group was 0.94 ± 0.42 and that of the control group was 1.29 ± 0.47 (p = 0.002), for "early satiety" the rate of the study group was 0.81 ± 0.30 and that of the control group was 1.08 ± 0.51 (p = 0.046), for "constipation" the rate of the study group was 0.85 ± 0.24 and that of the control group was 1.09 ± 0.38 (p = 0.002), and for "arthralgia" rate of the study group was 0.95 ± 0.26 and that of the control group was 1.40 ± 0.66 (p = 0.015). In every case the study group had significant improvement of the symptoms when compared to findings for the control group.
The "after-study score ÷ before-study score" of the "mental symptoms" listed in the common questionnaire was analyzed in a similar manner. Two items of 21 showed significant differences: for the "difficulty in falling asleep", the rate of the study group was 0.85 ± 0.24 and that of the control group was 1.38 ± 0.87 (p = 0.021), and for "pessimism", the rate of the study group was 0.87 ± 0.27 and that of the control group was 1.09 ± 0.41 (p = 0.050). In both items the symptoms in the study group were significantly improved compared to those of the control group.
·The benefits of walking
We studied the benefits of walking for 31 subjects (mean age 59.1 ± 5.0, 17 men and 14 women) from the study and control groups. There was no significant change in their weight and body mass index after the exercise. Slight significant decreases were found in total body water (-1.45%), lean body weight (-1.45%), and skeletal muscle volume (-2.10%) (p < 0.01).
Body fat amount increased significantly by 3.06% (p < 0.01) and body fat percentage also increased significantly by 1.95 % (p < 0.05). The waist-hip ratio (0.87%) and basal metabolism (-1.01%) changed slightly. Systolic blood pressure significantly decreased from 140.2 ± 23.2 mmHg to 134.2 ± 21.1 mmHg (-3.73%, p < 0.01), however, diastolic blood pressure changed from 90.5 ± 15.2 mmHg to 88.4 ± 14.9 mmHg (-1.81%), showing no significant change between before and after the study.
IGF-I levels changed from 176.4 ± 41.9 ng/ml to185.9 ± 68.2 ng/ml (3.21%), DHEA-s levels changed from 1169.3 ± 655.3 ng/ml to 1148.1 ± 689.7 ng/ml (-0.59%), and total testosterone levels (men only) changed from 362.1 ± 147.1 pg/ml to 353.6 ± 157.3 pg/ml (-2.81%). However, none of these levels showed a significant difference. Estrogen levels (only women) significantly increased from 13.4 ± 16.2 pg/ml to 19.2 ± 22.4 pg/ml (36.76%) (p < 0.01).
·Interrelationship between data
Before-study symptoms that correlate to age were "dizziness" (r = 0.4063, p < 0.05), "feeling of anxiety for no special reason" (r = 0.4557, p < 0.05), and weekly exercise habits (days of exercise a week) (r = 0.6142, p < 0.01). The decrease rate of weight from before-study to after-study improved according to the age increase (r = -0.3930, p < 0.05).
The items that had a sex difference were height, weight, body fat amount, total body water, muscle volume, lean body weight, skeletal muscle volume, basal metabolism, hemoglobin level, hematocrit, blood urea nitrogen levels, blood creatinine, uric acid, total cholesterol, low-density lipoprotein cholesterol, and DHEA-s levels.
Among "mental symptoms", "constipation", "cold skin" and "lose confidence" were significantly higher in women. Women also tended to have higher levels of total cholesterol and lowdensity lipoprotein cholesterol. The waist-hip ratio, which is strongly related to visceral fat retention, significantly correlated to basal metabolism (r = 0.4340, p < 0.05), "tendency to gain weight" (r = 0.3847, p<0.05), "skin problems" (r = -0.4193, p < 0.05), "epigastralgia" (r = -0.4413, p < 0.05), "diarrhea" (r = 0.4148, p < 0.05), "easily breaking into sweat" (r = 0.4819, p < 0.01) and "lose confidence" (r = -0.3999, p<0.05). High-density lipoprotein cholesterol levels tended to descend in inversely proportion to the increase of waist-hip ratio (r = -0.4902, p < 0.01).
By investigating the factors, the factors that affected an increased rate of estrogen levels from before-study to after-study were body fat percentage (r = -0.5756, p < 0.05), basal metabolism (r = -0.5638, p < 0.05), "tired eyes" (r = 0.5677, p < 0.05), "eye pain" (r = 0.6020, p < 0.05), "stiff shoulders" (r = 0.6735, p < 0.05), "palpitations" (r = 0.6050, p < 0.05), "anorexia"(r = 0.5802, p < 0.05), "difficulty in falling asleep" (r = -0.5964, p < 0.05), and "feeling of anxiety for no special reason" (r = 0.5622, p < 0.05).
Discussion ·The benefits of walking
There are many studies on the various influences of exercise such as walking to physical activity. A study of 18,766 women 70 to 81 years old who walked for long periods on a regular basis clarified that their cognitive function was significantly superior and its decline was relatively minor 8) . A study of 2,257 men 71 to 93 years old suggested that walking may reduce the risk of cognitive dysfunction and that promotion of an active lifestyle contributes to the retention of cognitive function for older men who can exercise 9) .
In this study, information on the effects of 2 months of walking on the body was obtained. The actual method of walking was mainly determined by the pace of individual subjects. In the study group a special measuring apparatus was used, however, it was only for guidance in maintaining exercise intensity. So the reality of the study is considered to be quite close to usual daily walking.
We feel that the 1% to 2% change of body composition was unremarkable but found the part of the body involved in the 3% increase in body fat to be very interesting. The cause was not clarified by this study, in which dietary intake was not strictly controlled.. It is not likely that the visceral fat increased because neither the waist-hip ratio nor the body proportions changed significantly.
Hematopoietic activity in bone marrow tends to decline when people reach the age of 40 years, and fibrosis of the bone marrow and a decrease in the number of adipose cells is observed 10) . The role of adipose cells in bone marrow is not known. Various adipocytokines may have positive effects on hematopoiesis when the levels of adipose cells are appropriate. Walking might have a preventive action against the degenerative changes seen in aging.
The role of adipose cells in bone marrow will be further investigated in the near future.
Generally, walking seems to have a positive effect on blood pressure. Especially, a significant beneficial effect on systolic blood pressure was observed in the study group. There were more subjects with relatively higher blood pressure in the study group than in the control group, even so it was considered that walking with an exercise intensity of 40% to 60% as determined by using a measuring device was more effective at lowering blood pressure.
It is interesting that the analysis of factors affecting afterstudy blood pressure lowering showed that subjects with fewer drinking days per week had a more significant reduction of blood pressure. Furthermore, the findings that subjects with relatively higher before-study blood pressure levels had a more significant lowering effect than did subjects with relatively normal blood pressure, suggest that walking is involved with maintaining homeostasis.
The ovarian function is affected by various factors such as mental stress, overworks, exercise or obesity. The hypothalamicpituitary-adrenal (HPA) axis, when activated by stress, exerts an inhibitory effect on the female reproductive system 11, 12) . Moderate exercise shows reverse action. It is compatible with our data that estrogen levels increased by 21% to 49%. Walking did not significantly affect the testosterone levels.
·Study group vs. control group
The result of the comparison on "after-study value ÷ beforestudy value" and "after-study score ÷ before-study score" in the study group vs. the control group is interesting. Although there was no difference between the study group and the control group in physical findings and blood test findings, there was a significant difference in the questionnaire evaluations between the 2 groups. In physical symptoms, "lethargy", "tinnitus", "early satiety", "constipation" and "arthralgia"; and in mental symptoms, "difficulty in falling asleep" and "pessimism" were significantly improved in the study group and rather exacerbated in the control group. There is no evidence indicating overload to cardiac capability. However, the score exacerbation of "arthralgia" indicates overload to joints. Walking of 40% to 60% of exercise intensity may be appropriate for joints.
·Exercise intensity of walking
There is a controversy among researchers about safe and effective walking with respect to its pace and distance. Generally the objective is to maintain exercise intensity within an appropriate range. The intensity of walking could be approximately determined by Karvonen's formula using "target heart rate" and "subjective symptoms" as variables 13, 14) .
For example, in a 60-year-old person whose resting heart rate is 70 beats per minute, the maximum heart rate is 160 beats per minute and the target heart rate is calculated as the following:
Target heart rate = (160 -70) 0.4 to 0.6 + 70 = 106 to124 beats per minute By using a watch-type measuring apparatus, subjects can easily and promptly monitor the change of heart rate and judge whether the heart rate is in the target range. Also heart rate can be immediately measured when dyspnea or palpitations is noticed to determine whether the heart is under excessive exercise load. We feel that the use of this measuring apparatus will simplify exercise training within a target heart rate.
·Measuring apparatus for exercise intensity
Until now, trials to estimate exercise intensities have used objective indices 15) , pedometers, and Karvonen's formula. In actuality it is difficult to estimate the intensities by using only pedometers 16) . The portable type "appropriate exercise intensity indicating apparatus," which can notify the extent of a moment by a buzzer sound has been developed but is not yet put to practical use 17, 18) .
In conclusion, the watch-type pedometer with self-contained heart rate measuring function and an audible warning is a practical device for maintaining the intensity of appropriate walking (40% to 60%). 
